Canada is spearheading a faster and more cost-effective way to translate university discoveries into new medicines. In 2013, Canada’s Centre for Drug Research and Development CECR partnered with top drug commercialization centres from five other countries to form the new Global Alliance of Leading Drug Discovery and Development Centres. Together, the six centres represent nearly 400 drug developers working with tens of thousands of academic scientists on more than 165 projects, often in partnership with the world’s biggest biopharmaceutical companies. They will eliminate redundancies in drug development by pooling resources and sharing technologies.